What does Cardio Diagnostics Holdings, Inc. do?
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an…
What is Cardio Diagnostics Holdings, Inc.'s P/E and P/B ratio?
Cardio Diagnostics Holdings, Inc. has a P/E ratio of -0.6 and a P/B ratio of 0.68.
What is Cardio Diagnostics Holdings, Inc.'s debt-to-equity ratio?
Cardio Diagnostics Holdings, Inc. has a debt-to-equity ratio of 0.05.
How much does Cardio Diagnostics Holdings, Inc. owe compared with what it owns?
Cardio Diagnostics Holdings, Inc. owes $0.06 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Cardio Diagnostics Holdings, Inc.'s Positivity rank?
Cardio Diagnostics Holdings, Inc. is ranked #1,377 of 6,774 companies globally and #299 of 4,000 in United States on PositoAI, with a Positivity Score of 22,864.
Does Cardio Diagnostics Holdings, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Cardio Diagnostics Holdings, Inc..
Where can I read the latest news about Cardio Diagnostics Holdings, Inc.?
Recent headlines about Cardio Diagnostics Holdings, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Cardio Diagnostics Holdings, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Cardio Diagnostics Holdings, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.